| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $42,916,182 ) (Continued on the next page) |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DE029862 | Validation of Light Scattering Spectroscopy for Intra-operative Margin Guidance during Oral Cancer Resection | 000 | 3 | NIH | 5/31/2022 | $709,868 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R18HS026177 | Demonstrating, testing, and disseminating a sustainable model for academic detailing programs | 004 | 5 | AHRQ | 8/23/2022 | $371,377 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK119542 | The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy | 001 | 3 | NIH | 5/27/2022 | $0 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK119542 | The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy | 000 | 3 | NIH | 4/12/2022 | $185,204 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI147316 | Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL) | 000 | 4 | NIH | 8/1/2022 | $625,923 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01CA238335 | Digital Health Supported Weight Management Intervention Delivered by Community Health Workers among Public Housing Residents | 001 | 3 | NIH | 4/25/2022 | $54,705 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01CA238335 | Digital Health Supported Weight Management Intervention Delivered by Community Health Workers among Public Housing Residents | 000 | 3 | NIH | 2/18/2022 | $615,409 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL141774 | Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology | 002 | 4 | NIH | 6/29/2022 | $157,488 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL141774 | Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology | 001 | 4 | NIH | 3/17/2022 | $77,320 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL141774 | Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology | 000 | 4 | NIH | 3/14/2022 | $721,495 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH118373 | Reducing Duration of Untreated Psychosis through Motivational Interviewing for Loved Ones | 002 | 5 | NIH | 7/6/2022 | $155,531 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AT010487 | Improving Access to Chiropractic Care for Low Back Pain in Underserved Primary Care Settings: Development and Evaluation of a Multi-level Implementation Strategy | 000 | 4 | NIH | 8/29/2022 | $160,381 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K24AI145661 | HIV-1 mucosal transmission and persistence | 000 | 4 | NIH | 3/24/2022 | $181,673 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UM1DA049412 | MassHEAL - Reducing overdose deaths by 40% (2019-2023) | 003 | 4 | NIH | 6/27/2022 | $4,230,000 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UM1DA049412 | MassHEAL - Reducing overdose deaths by 40% (2019-2023) | 001 | 4 | NIH | 4/14/2022 | $3,000,000 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UM1DA049412 | MassHEAL - Reducing overdose deaths by 40% (2019-2023) | 002 | 4 | NIH | 4/15/2022 | $67,800 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | ASTWH220118 | Centering(patientswith)Fibroids | 00 | 1 | DHHS/OS | 9/12/2022 | $269,621 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21AI167369 | Dissecting the mechanisms of intestinal epithelial injury by Ebola virus using iPSC-derived intestinal organoids | 000 | 1 | NIH | 7/5/2022 | $273,750 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA054328 | Improving value-based healthcare delivery for opioid use disorder | 000 | 2 | NIH | 5/24/2022 | $175,889 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | H9746074 | Special Projects of National Significance - Demonstration/Implementation Sites | 00 | 1 | HRSA | 6/28/2022 | $299,997 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | UT939477 | Support for Fetal Alcohol Spectrum Disorders (FASD) prevention, identification, and intervention | 00 | 3 | HRSA | 7/12/2022 | $956,211 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | T2537593 | Addiction Medicine Fellowship | 00 | 3 | HRSA | 5/10/2022 | $785,601 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | T3442136 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 03 | 2 | HRSA | 8/18/2022 | $4,245 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | T3442136 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 02 | 2 | HRSA | 7/14/2022 | $0 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | T3442136 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 01 | 2 | HRSA | 7/12/2022 | $0 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | T3442136 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 00 | 2 | HRSA | 5/12/2022 | $592,191 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | R4145950 | Autism Secondary Data Analysis Research (SDAR) Program | 00 | 1 | HRSA | 6/23/2022 | $99,888 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R4145950 | Autism Secondary Data Analysis Research (SDAR) Program | 01 | 1 | HRSA | 9/7/2022 | $0 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DA052674 | Tailored Contraceptive Decision Support for Pregnant Women with Opioid Use Disorder | 000 | 1 | NIH | 4/14/2022 | $189,431 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA052821 | Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) | 000 | 1 | NIH | 5/11/2022 | $175,574 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK113252 | Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community | 001 | 5 | NIH | 7/29/2022 | $0 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK113252 | Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community | 000 | 5 | NIH | 11/17/2021 | $188,447 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH117221 | An implementation science approach to optimizing evidence-based treatments for posttraumatic stress disorder (PTSD) for non-specialty settings | 000 | 5 | NIH | 7/12/2022 | $184,483 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH128639 | Medicaid Accountable Care Organizations (ACO) and Quality of Care for Adults with Serious Mental Illness (SMI) | 000 | 1 | NIH | 3/14/2022 | $189,432 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI152930 | Understanding HIV's impact on RR/MDR-TB development and transmission through genomics | 000 | 2 | NIH | 5/17/2022 | $187,485 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23ES028736 | Effects of maternal thyroid function and thyroidal disruptor exposure on pregnancy and child developmental outcomes | 000 | 4 | NIH | 5/31/2022 | $205,326 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL145126 | Improving Prehospital Pediatric Emergency Readiness with Telemedicine | 000 | 3 | NIH | 8/2/2022 | $166,321 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R13HS028936 | NaRCAD's International Conference Series: An Innovative Model to Advance the Field of Clinical Outreach Education | 000 | 1 | AHRQ | 9/21/2022 | $45,625 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI172843 | Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission | 000 | 1 | NIH | 9/19/2022 | $699,829 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AA030460 | Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" | 000 | 1 | NIH | 9/19/2022 | $738,455 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21TW012165 | Simulator-Based simplified Focused Cardiac Ultrasound (sFoCUS) Training in Haiti | 000 | 1 | NIH | 6/22/2022 | $314,663 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01CA273208 | Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care | 000 | 1 | NIH | 7/14/2022 | $670,251 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | S10OD032333 | Sartorious Octet R8 System | 000 | 1 | NIH | 6/17/2022 | $249,082 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | NU2GGH002322 | Chagas Education for Essential Providers (CEEP) | 00 | 3 | CDC | 8/4/2022 | $150,000 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | 90ZT0224 | The Moving Forward Initiative for Survivors of Torture and Their Families | 00 | 1 | ACF | 9/27/2022 | $475,000 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R56HL157367 | Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy | 000 | 1 | NIH | 9/16/2022 | $817,568 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD096798 | Safety, Efficacy, Pharmacokinetics, and Pharmacogenomics of Extended-Release Naltrexone in Pregnant Women - Administrative Supplement | 001 | 5 | NIH | 7/22/2022 | $120,476 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD096798 | Safety, Efficacy, Pharmacokinetics, and Pharmacogenomics of Extended-Release Naltrexone in Pregnant Women - Administrative Supplement | 000 | 5 | NIH | 5/9/2022 | $613,662 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK133404 | Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration | 000 | 1 | NIH | 5/31/2022 | $596,381 |
|
